跳至主要内容
临床试验/NCT01310075
NCT01310075已完成不适用

Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction: A Blinded, Prospective, Randomized, Controlled Trial

M.D. Anderson Cancer Center2 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2011年2月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
90
试验地点
2
主要终点
Number of Participants With Complications After Tissue Expander Replacement With Implant

研究概览

简要总结

The goal of this clinical research study is to learn if the complication rate and post-surgical appearance differ based on what type of mesh is used for breast reconstruction surgery.

详细描述

If you agree to take part in this study, you will be randomly assigned (as in the roll of a dice) to receive Surgimend mesh or Alloderm mesh.

Breast Reconstruction Surgery:

All techniques of the breast reconstruction surgery are considered to be standard of care. You will be given a separate consent form to sign that explains the procedure and risks in more detail.

Data Collection:

Information about you will be collected, including your age, height, weight, breast size, past medical and smoking history, tumor size and location, and the surgical method used for the breast reconstruction surgery.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients undergoing immediate tissue expander reconstruction following mastectomy by any of the surgeon co-investigators are eligible for the study.
  • Patients 18 years of age or older are eligible for the study.
  • Patients undergoing skin-sparing mastectomy utilizing bioprosthetic mesh are eligible for the study.
  • Patients who have not undergone autologous tissue breast reconstruction and intend to undergo implant only breast reconstruction.
  • Patients who intend to remain under the MDACC surgeon's care until completion of the reconstruction.

排除标准

  • Patients with prior radiation to the breast/chest wall of the ipsilateral breast .
  • Patients who cannot be effectively reconstructed without the use of bioprosthetic mesh.
  • Patients who are current smokers.
  • Patients requiring additional intra-operative skin resections of greater than 1cm beyond the skin edge as a result of mastectomy flap devascularization.
  • Patients who have a history of breast tissue expander or implant placement.

研究组 & 干预措施

Alloderm Mesh

Experimental

Alloderm Mesh - 6 x 12 cm piece or 6 x 16 cm piece is trimmed into a semicircle and sewn into the inframammary fold using vicryl. The smooth side is placed against the implant.

干预措施: Alloderm (Device)

Surgimend Mesh

Experimental

Surgimend Mesh - 10 x 15 cm piece of fenestrated material is sewn to the fold, curved side along the fold, using vicryl suture.

干预措施: Surgimend (Device)

Control (no mesh)

No Intervention

结局指标

主要结局

Number of Participants With Complications After Tissue Expander Replacement With Implant

时间窗: through study completion, an average of 1 year

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Bioprosthetic Mesh to Expand the Lower Pole in... | 临床试验